dc.contributor.author | Kar, Debasmita | |
dc.contributor.author | Roy, Subho | |
dc.date.accessioned | 2024-07-25T10:40:31Z | |
dc.date.available | 2024-07-25T10:40:31Z | |
dc.date.issued | 2024-07-03 | |
dc.identifier.issn | 1898-6773 | |
dc.identifier.uri | http://hdl.handle.net/11089/52899 | |
dc.description.abstract | Menopausal transition and post-menopausal periods can have short-term and long- term effects on mid-life health of women. The short-term effects include the possibility of experiencing of menopausal symptoms, while the long-term effects include cardiovascular diseases (CVD) risk. The occurrence of menopausal symptoms varies widely within and between populations. Studies indicate that the frequency and severity of menopausal symptoms are linked to CVD risk factors, but the existing literature is divergent and somewhat limited. Thus, women belonging to different populations are likely to be at a different risk of CVD, but the exact physiological mechanism behind this relationship remains unclear. The present narrative review aimed to synthesize the available evidence of menopausal symptoms in association with various conventional CVD risk factors such as blood pressure, total cholesterol and blood glucose levels and obesity, as well as to determine the potential link between these two processes. We undertook a rigorous data base search to identify, examine, and critically assess the existing literature on the associations between menopausal symptoms and CVD risk factors. We applied inclusion and exclusion criteria to filter the retrieved articles and classified the literature into eight major categories. The risk of CVD is higher among women who experience vasomotor, psychological, and urogenital symptoms compared to those who do not experience these symptoms. Our review indicates that menopausal symptoms can be used as markers in assessing CVD risk factors during midlife. Thus there is a need for larger-scale research to support these findings and identify the potential mediators that are controlling this association. | en |
dc.language.iso | en | |
dc.publisher | Wydawnictwo Uniwersytetu Łódzkiego | pl |
dc.relation.ispartofseries | Anthropological Review;2 | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | |
dc.subject | cardiovascular disease | en |
dc.subject | menopausal symptoms | en |
dc.subject | vasomotor symptoms | en |
dc.subject | psychological symptoms | en |
dc.subject | postmenopausal women | en |
dc.subject | insulin resistance | en |
dc.subject | lipid profile | en |
dc.subject | blood pressure level | en |
dc.title | A review on association between menopausal symptoms and cardiovascular risk factors | en |
dc.type | Article | |
dc.page.number | 127-146 | |
dc.contributor.authorAffiliation | Kar, Debasmita - University of Kolkata, Department of Anthropology, India | en |
dc.contributor.authorAffiliation | Roy, Subho - Indian Statistical Institute, Biological Anthropology Unit, Kolkata, India | en |
dc.identifier.eissn | 2083-4594 | |
dc.references | Ali AM, Ahmed AH, Smail L. 2020. Psychological climacteric symptoms and attitudes toward menopause among Emirati women. Int J Environ Res Public Health 17(14): 5028. https://doi.org/10.3390/ijerph17145028 | en |
dc.references | Armeni A, Anagnostis P, Armeni E, Mili N, Goulis D, Lambrinoudaki I. 2023. Vasomotor symptoms and risk of cardiovascular disease in peri and postmenopausal women: A systematic review and meta-analysis. Maturitas 171: 13–20. https://doi.org/10.1016/j.maturitas.2023.02.004 | en |
dc.references | Avis NE, Crawford SL, Greendale G, Bromberger JT, Everson-Rose SA, Gold EB, et al. 2015. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 175(4): 531–539. https://doi.org/10.1001/jamainternmed.2014.8063 | en |
dc.references | Bechlioulis A, Kalantaridou SN, Naka KK, Chatzikyriakidou A, Calis KA, Makrigiannakis A, et al. 2010. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 95(3): 2009–2062. https://doi.org/10.1210/jc.2009-2262 | en |
dc.references | Beussink-Nelson L, Baldridge AS, Hibler E, Bello NA, Epps K, Cameron KA, et al. 2022. Knowledge and perception of cardiovascular disease risk in women of reproductive age. Am J Prev Cardiol 11: 100364. https://doi.org/10.1016/j.ajpc.2022.100364 | en |
dc.references | Brunner EJ, Shipley MJ, Britton AR, Stansfeld SA, Heuschmann PU, Rudd AG, et al. 2014. Depressive disorder, coronary heart disease, and Stroke: dose-response and reverse causation effects in the Whitehall II cohort study. Eur J Prev Cardiol 21(3): 340–346. https://doi.org/10.1177/2047487314520785 | en |
dc.references | Cagnacci A, Cannoletta M, Caretto S, Zanin R, Xholli A, Volpe A. 2011. Increased cortisol level: a possible link between climacteric symptoms and cardiovascular factors. Menopause 18 (3): 273–278. https://doi.org/10.1097/gme.0b013e3181f31947 | en |
dc.references | Cagnacci A, Cannoletta M, Palma F, Zanin R, Xholli A, Volpe A. 2012. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause. Climacteric 15(2): 157–162. https://doi.org/10.3109/13697137.2011.617852 | en |
dc.references | Cagnacci A, Palma F, Romani C, Xholli A, Bellafronte M, Di Carlo C. 2015. Are climacteric complaints associated with risk factors of cardiovascular disease in peri-menopausal women? Gynecol Endocrinol 31(5): 1–5. https://doi.org/10.3109/09513590.2014.998188 | en |
dc.references | Cagnacci A, Gambera A, Bonaccorsi G, Xholli A. 2022. Relation between blood pressure and genitor-urinary symptoms in the years across the menopausal age. Climacteric 25(4): 395–400. https://doi.org/10.1080/13697137.2021.2006176 | en |
dc.references | Cakmak HA, Cakmak BD, Yumru AE, Aslan S, Enhos A, Kalkan AK, et al. 2015. The relation between blood pressure, blood glucose and bone mineral density in postmenopausal Turkish women. Ther Clin Risk Manag 11:1641–1648. https://doi.org/10.2147/TCRM.S95017 | en |
dc.references | Carney RM, Freedland KE, Veith RC. 2005. Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med 67 (Suppl 1): S29–33. https://doi.org/10.1097/01.psy.0000162254.61556.d5 | en |
dc.references | Cappuccio FP, D’Elia L, Strazzullo P, Miller MA. 2010. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 33(2):414–420. https://doi.org/10.2337/dc09-1124 | en |
dc.references | Cappuccio FP, Cooper D, D’Elia L, Strazzullo P, Miller MA. 2011. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J 32(12):148–192. https://doi.org/10.1093/eurheartj/ehr007 | en |
dc.references | Carr MC. 2003. The emergence of metabolic syndrome with menopause. J Clin Endocrinol Metab 88(6): 2404–2411. https://doi.org/10.1210/jc.2003-030242 | en |
dc.references | Cohen L, Soares C, Vitonis AF, Otto MW, Harlow BL. 2006. Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry 63(4): 385–390. https://doi.org/10.1001/archpsyc.63.4.385 | en |
dc.references | Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al. 2007. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 28(16):2028–2040. https://doi.org/10.1093/eurheartj/ehm296 | en |
dc.references | Da Fonseca AM, Bagnoli VR, Souza MA, Azevedo RS, Couto EDB Jr, Soares JM Jr, et al. 2013. Impact of Age and Body Mass on the Intensity of Menopausal Symptoms in 5968 Brazilian Women. Gynecol Endocrinol 29(2):116–118. https://doi.org/10.3109/09513590.2012.730570 | en |
dc.references | Dam V, Dobson AJ, Onland-Moret NC, van der Schouw YT, Mishra GD. 2020. Vasomotor menopausal symptoms and cardiovascular disease risk in midlife: A longitudinal study. Maturitas 133: 32–41. https://doi.org/10.1016/j.maturitas.2019.12.011 | en |
dc.references | De Wit LM, Van Straten A, Van Herten N, Penninx BW, Cuijpers P. 2009. Depression and body mass index, a u shaped association. BMC Public Health 9:14. https://doi.org/10.1186/1471-2458-9-14 | en |
dc.references | Dennerstein L, Dudley EC, Hopper JL, Guthrie JR, Burger HG. 2000. A prospective population-based study of menopausal symptoms. Obstet Gynecol 96(3): 351–358. https://doi.org/10.1016/s0029-7844(00)00930-3 | en |
dc.references | Duffy OK, Iversen L, Hannaford PC. 2013. Factors Associated With Reporting Classic Menopausal Symptoms Differ. Climacteric 16(2):240–251. https://doi.org/10.3109/13697137.2012.697227 | en |
dc.references | El Khoudary SR, Aggarwal B, Beckie TM, Hodis HN, Johnson AE, Langer RD, et al. 2020. Menopause transition and cardiovascular disease risk: Implications for timing of early prevention: A scientific statement from the American Heart Association. Circulation 142 (25):e506–e532. https://doi.org/10.1161/CIR.0000000000000912 | en |
dc.references | Elavsky S, Gold CH. 2009. Depressed mood but not fatigue mediate the relationship between physical activity and perceived stress in middle-aged women. Maturitas 64(4): 235–240. https://doi.org/10.1016/j.maturitas.2009.09.007 | en |
dc.references | Engler MB, Engler MM. 1995. Assessment of the cardiovascular effects of stress. J Cardiovasc Nurs 10(1): 51–63. https://doi.org/10.1097/00005082-199510000-00005 | en |
dc.references | Esler M, Alvarenga M, Lambert G, Kaye D, Hastings J, Jennings G, et al. 2004. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Ann N Y Acad Sc 1018:505–514. https://doi.org/10.1196/annals.1296.062 | en |
dc.references | Ferketich AK, Schwartzbaum JA, Frid DJ, Moeschberger ML. 2000. Depression as an Antecedent to Heart Disease Among Women and Men in the NHANES I Study. Arch Intern Med 160(9):1261–1268. https://doi.org/10.1001/archinte.160.9.1261 | en |
dc.references | Franco OH, Muka T, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, et al. 2015. Vasomotor symptoms in women and cardiovascular risk markers: Systematic review and meta-analysis. Maturitas 81(2015): 353–361. https://doi.org/10.1016/j.maturitas.2015.04.016 | en |
dc.references | Freedman RR, Krell W. 1999. Reduced thermoregulatory null zone in postmenopausal women with hot flashes. Am J Obstet Gynecol 181(1): 66–70. https://doi.org/10.1016/s0002-9378(99)70437-0 | en |
dc.references | Freedman RR. 2005. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 23(2): 117–125. https://doi.org/10.1055/s-2005-869479 | en |
dc.references | Freeman EW. 2015. Depression in the menopause transition: risks in the changing hormone milieu as observed in the general population. Womens Midlife Health 1:2. https://doi.org/10.1186/s40695-015-0002-y | en |
dc.references | Fusco F, D’Anzeo G, Sessa A, Pace G, Rossi A, Capece M, et al. 2013. BPH/LUTS and ED: common pharmacological pathways for a common treatment. J Sex Med 10(10):2382–2393. https://doi.org/10.1111/jsm.12261 | en |
dc.references | Gallicchio L, Miller SR, Kiefer J, Greene T, Zacur HA, Flaws JA. 2010. Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the midlife women’s health study. Menopause 22(10): 1098–1107. https://doi.org/10.1097/GME.0000000000000434 | en |
dc.references | Gallichio L, Miller SR, Kiefer J, Greene T, Zacur HA, Flaws JA. 2014. Change in body mass index, weight, and hot flashes: a longitudinal analysis from the midlife women’s health study. J Womens Health. 23(3): 231–237. https://doi.org/10.1089/jwh.2013.4526 | en |
dc.references | Gast GC, Grobbee DE, Pop VJM, Keyzer JJ, Wijnands-van Gent CJM, Samsioe GN, et al. 2008. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 51(6): 1492–1498. https://doi.org/10.1161/HYPERTENSIONAHA.107.106526 | en |
dc.references | Gast GCM, Pop VJM, Samsioe GN, Grobbee DE, Nilsson PM, Keyzer JJ, et al. 2011. Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease. Menopause 18(2): 146–151. https://doi.org/10.1097/gme.0b013e-3181f464fb | en |
dc.references | Gava G, Orsili I, Alvisi S, Mancini I, Seracchioli R, Meriggiola MC. 2019. Cognition, Mood and Sleep in Menopausal Transition: The Role of Menopause Hormone Therapy. Medicina (Kaunas) 55(10):668. https://doi.org/10.3390/medicina55100668 | en |
dc.references | Glaus J, Cui L, Hommer R, Merikangas KR. 2019. Association between mood disorders and BMI/overweight using a family study approach. J Affect Disord 248:131–138. https://doi.org/10.1016/j.jad.2019.01.011 | en |
dc.references | Gray KE, Katon JG, LaBlanc ES, Woods NF, Bastian LA, Reiber GE, et al. 2018. Vasomotor symptom characteristics: are they risk factors for incident diabetes? Menopause 25(5): 520–530. https://doi.org/10.1097/GME.0000000000001033 | en |
dc.references | Gupta P, Harte A, Sturdee DW, Sharma A, Barnett AH, Kumar S, et al. 2008. Effects of menopausal status on circulating calcitonin age-related peptide and adipokines: implications for insulin resistance and cardiovascular risks. Climacteric 11(5): 364–372. https://doi.org/10.1080/13697130802378493 | en |
dc.references | Herber-Gast GCM, Mishra GD, van der Schouw YT, Brown WJ, Dobson AJ. 2013. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause 20(9): 953–959. https://doi.org/10.1097/GME.0b013e-3182844a7c | en |
dc.references | Hitchcock CL, Elliott TG, Norman EG, Stajic V, Teede H, Prior JC. 2012. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women. Menopause 19(11):1208–1214. https://doi.org/10.1097/gme.0b013e31825541cc | en |
dc.references | Huang WY, Chang CC, Chen DR, Kor CT, Chen TY, Wu HM. 2017. Circulating leptin and adiponectin are associated with insulin resistance in healthy postmenopausal women with hot flashes. Plos One 12 (4). https://doi.org/10.1371/journal.pone.0176430 | en |
dc.references | Hunskaar S. 2008. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn 27 (8): 749–757. https://doi.org/10.1002/nau.20635 | en |
dc.references | Hwang EC, Kim SO, Nam DH, Yu HS, Hwang I, Jung SI, et al. 2015. Men with Hypertension are More Likely to Have Severe Lower Urinary Tract Symptoms and Large Prostate Volume. Low Urin Tract Symptoms 7(1):32–36. https://doi.org/10.1111/luts.12046 | en |
dc.references | Im EO, Kim J, Chee E, Chee W. 2016. The Relationships between Psychological Symptoms and Cardiovascular Symptoms Experienced during Menopausal Transition: Racial/Ethnic Differences. Menopause 23(4): 396–402. https://doi.org/10.1097/GME.0000000000000545 | en |
dc.references | Jackson EA, El Khoudary SR, Crawford SL, Matthews K, Joffe H, Chae C, et al. 2016. Hot flash frequency and blood pressure: Data from the Study of Women’s Health Across the Nation. J WomensHealth( Larchmt) 25(12): 1204–1209. https://doi.org/10.1089/jwh.2015.5670 | en |
dc.references | Kagitani H, Asou Y, Ishihara N, Hoshide S, Kario K. 2014. Hot flashes and blood pressure in middle-aged Japanese women. Am J Hypertens 27(4): 503–507. https://doi.org/10.1093/ajh/hpt125 | en |
dc.references | Kaneita Y, Uchiyama M, Yoshiike N, Ohida T. 2008. Associations of usual sleep duration with serum lipid and lipoprotein levels. Sleep 31(5):645–652. https://doi.org/10.1093/sleep/31.5.645 | en |
dc.references | Kershaw EE, Flier JS. 2004. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89(6): 2548–2556. https://doi.org/10.1210/jc.2004-0395 | en |
dc.references | Khakpash M, Khosravi A, Emamian MH, Hashemi H, Fotouhi A, Khajeh M. Association between sleep quality and duration with serum lipid profiles in older adults: A population-based study. Endocrine and Metabolic Science 13:100148. https://doi.org/10.1016/j.endmts.2023.100148 | en |
dc.references | Kiecolt-Glaser JK, Habash DL, Fagundes CP, Andridge R, Peng J, Malarkey WB, et al. 2015. Daily stressors, past depression, and metabolic responses to highfat meals: a novel path to obesity. Biol Psychiatry 77(7): 653–660. https://doi.org/10.1016/j.biopsych.2014.05.018 | en |
dc.references | Kilinc MF, Yasar E, Aydin HI, Yildiz Y, Doluoglu OG. 2018. Association between coronary artery disease severity and overactive bladder in geriatric patients. World J Urol 36 (1):35–40. https://doi.org/10.1007/s00345-017-2098-1 | en |
dc.references | Lallukka T, Haario P, Lahelma E, Rahkonen O. 2012. Associations of relative weight with subsequent changes over time in insomnia symptoms: a follow up study among middle aged women and men. Sleep Med 13 (10): 1271–1279. https://doi.org/10.1016/j.sleep.2012.06.020 | en |
dc.references | Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I. 2014. Insomnia and the risk of incident heart failure: a population study. Eur Heart J 35(21):1382–1393. https://doi.org/10.1093/eurheartj/eht019 | en |
dc.references | Lee SH, Lee SK, Choo MS, Ko KT, Shin TY, Lee WK, et al. 2015. Relationship between Metabolic Syndrome and Lower Urinary Tract Symptoms: Hallym Aging Study. Biomed Res Int 2015:130917. https://doi.org/10.1155/2015/130917 | en |
dc.references | Lee HY, Moon JE, Sun HY, Doo SW, Yang WJ, Song YS, et al. 2019. Association between lower urinary tract symptoms and cardiovascular risk scores in ostensibly healthy women. BJU Int 123(4):669–675. https://doi.org/10.1111/bju.14577 | en |
dc.references | Li, Q. 2021. The association between sleep duration and excess body weight of the American adult population: a cross-sectional study of the national health and nutrition examination survey 2015–2016. BMC Public Health 21(1):335. https://doi.org/10.1186/s12889-021-10369-9 | en |
dc.references | Lin HJ, Weng SF, Yang CM, Wu MP. 2013. Risk of hospitalization for acute cardiovascular events among subjects with lower urinary tract symptoms: a nationwide population-based study. PLoS One 8(6):e66661. https://doi.org/10.1371/journal.pone.0066661 | en |
dc.references | Low CA, Thurston RC, Matthews KA. 2010. Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom Med 72(9): 842–854. https://doi.org/10.1097/PSY.0b013e3181f6934f | en |
dc.references | Matthews KA, Chen X, Barinas-Mitchell E, Brooks MM, Derby CA, Harlow S, et al. 2021. Age at menopause in relationship to lipid change sand subclinical carotid disease across 20 years: Study of women’s health across the nation. J Am Heart Assoc 10(18): e021362. https://doi.org/10.1161/JAHA.121.021362 | en |
dc.references | Mendelson ME, Kara RE. 1999. Mechanisms of Disease. NEJM 340:1801–1810. | en |
dc.references | Mittleman MA, Mostofsky E. 2011. Physical, psychological and chemical triggers of acute cardiovascular events: preventive strategies. Circulation 124(3):346–354. https://doi.org/10.1161/CIRCULATIONAHA.110.968776 | en |
dc.references | Moazzami K, Lima BB, Sullivan S, Shah A, Bremner JD, Vaccarino V. 2019. Independent and joint association of obesity and metabolic syndrome with depression and inflammation. Health Psychol 38(7): 586–595. https://doi.org/10.1037/hea0000764 | en |
dc.references | Muka T, Oliver-Williams C, Colpani V, Kunutsor S, Chowdhury S, Chowdhury R, et al. 2016. Association of vasomotor and other menopausal symptoms with risk of cardiovascular disease: A systematic review and meta-analysis. PloS One 11(6):e0157417. https://doi.org/10.1371/journal.pone.0157417 | en |
dc.references | Myint PK, Welch AA, Luben RN, Wainwright NWJ, Surtees PG, Bingham SA, et al. 2006. Obesity Indices and Self-Reported Functional Health in Men and Women in the EPIC-Norfolk. Obesity (Silver Spring) 14(5):884–893. https://doi.org/10.1038/oby.2006.102 | en |
dc.references | Nemeroff CB. 2008. The curiously strong relationship between cardiovascular disease and depression in the elderly. Am J Geriatr Psychiatry 16(11):857–860. https://doi.org/10.1097/JGP.0b013e318189806a | en |
dc.references | Nguyen TMD. 2020. Adiponectin: Role in Physiology and Pathophysiology. Intern J Prev Med 11:136. https://doi.org/10.4103/ijpvm.IJPVM_193_20 | en |
dc.references | Ohayon MM, Carskadon MA, Guilleminault C, Vitiello MV. 2004. Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan. Sleep 27(7):1255–1273. https://doi.org/10.1093/sleep/27.7.1255 | en |
dc.references | Player MS, Peterson LE. 2011. Anxiety disorders, hypertension and cardiovascular risk: a review. Int J Psychiatry Med 41(4): 365–377. https://doi.org/10.2190/PM.41.4.f | en |
dc.references | Randolph JF, Sowers MF, Bondarenko I, Gold EB, Greendale GA, Bromberger JT, et al. 2005. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 90(11):6106–6112. https://doi.org/10.1210/jc.2005-1374 | en |
dc.references | Russo GI, Castelli T, Privitera S, Fragalà E, Favilla V, Reale G, et al. 2015. Increase of Framingham cardiovascular disease risk score is associated with severity of lower urinary tract symptoms. BJU Int 116(5):791–796. https://doi.org/10.1111/bju.13053 | en |
dc.references | Santoro N, Epperson CN, Mathews SB. 2015. Menopausal symptoms and their management. Endocrinol Metab Clin North Am 44(3): 497–515. https://doi.org/10.1016/j.ecl.2015.05.001 | en |
dc.references | Schlaich M, Straznicky N, Lambert E, Lambert G. 2015. Metabolic Syndrome: A Sympathetic Disease? Lancet Diabetes Endocrinol 3(2):148–157. https://doi.org/10.1016/S2213-8587(14)70033-6 | en |
dc.references | Schmitz N, Deschênes SS, Burns RJ, Danna SM, Franco OH, Ikram MA, et al. 2018. Cardiometabolic dysregulation and cognitive decline: potential role of depressive symptoms. Br J Psychiatry 212(2): 96–102. https://doi.org/10.1192/bjp.2017.26 | en |
dc.references | Semczuk-Kaczmarek K, Rys-Czaporowska A, Platek AE, Szymanski FM.2021. Prevalence of lower urinary tract symptoms in patients with cardiovascular disease. Cent European J Urol 74(2):190–195. https://doi.org/10.5173/ceju.2021.0370.R1 | en |
dc.references | Sherman S, Miller H, Nerukar L. 2005. NIH state-of-the-science conference on management related symptoms. American Journal of Medicine 22(1): 1–38. | en |
dc.references | Smoller JW, Pollack MH, Wassertheil-Smoller S, Barton B, Hendrix SL, Jackson RD, et al. 2003. Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women’s Health Initiative. Arch Intern Med 163(17):2041–2050. https://doi.org/10.1001/archinte.163.17.2041 | en |
dc.references | Son MK, Lim NK, Lim J, Cho J, Chang Y, Park H. 2015. Difference in blood pressure between early and late menopausal transition was significant in healthy Korean women. BMC Womens Health 15:64. https://doi.org/10.1186/s12905-015-0219-9 | en |
dc.references | Steptoe A, Donald AE, O’Donnell K, Marmot M, Deanfield JE. 2006. Delayed blood pressure recovery after psychological stress is associated with carotid intima-media thickness: Whitehall psychology study. Arterioscler Thromb Vasc Biol 26 (11): 2547–2551. https://doi.org/10.1161/01.ATV.0000242792.93486.0d | en |
dc.references | Subak LL, RichterHE, Hunskaar S. 2009. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol 182(6Suppl): S2–S7. https://doi.org/10.1016/j.juro.2009.08.071 | en |
dc.references | Svartberg J, von Muhlen D, Kritz-Silverstein D, Barrett-Connor E. 2009. Vasomotor symptoms and mortality: the Rancho Bernardo Study. Menopause 16(5):888–891. https://doi.org/10.1097/gme.0b013e3181a4866b | en |
dc.references | Szmuilowicz ED, Mansion JE, Rossouw JE, Howard BV, Margolis KL, Greep NC, et al. 2011.Vasomotor symptoms and cardiovascular events among postmenopausal women. Menopause 18(6): 603–610. https://doi.org/10.1097/gme.0b013e3182014849 | en |
dc.references | Taheri S, Lin L, Austin D, Young T, Mignot E. 2004. Short sleep duration is associat ed with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1(3):e62. https://doi.org/10.1371/journal.pmed.0010062 | en |
dc.references | Tang R, Fan Y, Luo M, Zhang D, Xie Z, Huang F, et al. 2022. General and central obesity are associated with increased severity of VMS and sexual symptoms of menopause among Chinese women: A longitudinal study. Front Endocrinol (Lausanne) 13:814872. https://doi.org/10.3389/fendo.2022.814872 | en |
dc.references | Tedesco LMR, Di Giuseppe G, Napolitano F, Angelillo IF. 2015. Cardiovascular diseases and women: knowledge, attitudes, and behavior in the general population in Italy. Biomed Res Int 2015: 324692. https://doi.org/10.1155/2015/324692 | en |
dc.references | Thurston RC, Bromberger JT, Joffe H, Avis NE, Hess R, Crandall CJ, et al. 2008. | en |
dc.references | Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 15(5): 841–847. https://doi.org/10.1097/gme.0b013e318168f09b | en |
dc.references | Thurston RC, El Khoudary SR, Sutton-Tyrrell K, Crandall CJ, Gold E, SternfeldB et al. 2012. Vasomotor symptoms and lipid profile in women transitioning through menopause. ObstetGynecol 119(4): 753–761. https://doi.org/10.1097/AOG.0b013e-31824a09ec | en |
dc.references | Thurston RC, Chang Y, Mancuso P, Matthews KA. 2013. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women’s Health Across the Nation. FertilSteril 100(3): 793–800. https://doi.org/10.1016/j.fertnstert.2013.05.005 | en |
dc.references | Thurston RC, Matthews KA, Chang Y, Santoro N, Barinas-Mitchell E, von Kȁnel R et al. 2016. Changes in heart rate variability during vasomotor symptoms among midlife women. Menopause 23(5): 499–505. https://doi.org/10.1097/GME.0000000000000586 | en |
dc.references | Thurston RC, Johnson BD, Shufelt CL, Braunstein GD, Berga SL, Stanczyc FZ, et al. 2017. Menopausal symptoms and cardiovascular disease mortality in Women’s Ischemia Syndrome Evaluation (WISE). Menopause 24 (2):126–132. https://doi.org/10.1097/GME.0000000000000731 | en |
dc.references | Thurston RC. 2018. Vasomotor symptom: natural history, physiology, and links with cardiovascular health. Climacteric 21(2): 96–100. https://doi.org/10.1080/13697137.2018.1430131 | en |
dc.references | Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M. 2016. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 37(42): 3232–3245. https://doi.org/10.1093/eurheartj/ehw334 | en |
dc.references | Tsiptsios D, Leontidou E, Fountoulakis PN, Ouranidis A, Matziridis A, Manolis A, et al. 2022. Association between sleep insufficiency and dyslipidemia: a cross-sectional study among Greek adults in the primary care setting. Sleep Sci 15(Spec 1):49–58. https://doi.org/10.5935/1984-0063.20200124 | en |
dc.references | Tuomikoski P, Pelton HS. 2017. Vasomotor symptoms and metabolic syndrome. Maturitas 97: 61–65. https://doi.org/10.1016/j.maturitas.2016.12.010 | en |
dc.references | Walters K, Rait G, Petersen I, Williams R, Nazareth I. 2008. Panic disorder and risk of new onset coronary heart disease, acute myocardial infarction, and cardiac mortality: cohort study using the general practice database. Eur Heart J 29(24): 2981–2988. https://doi.org/10.1093/eurheartj/ehn477 | en |
dc.references | Ward KD, Sparrow D, Landsberg L, Young JB,Vokonas PS, Weiss ST. 1994. The relationship of epinephrine excretion to serum lipid levels: the Normative Aging Study. Metabolism 43(4): 509–513. https://doi.org/10.1016/0026-0495(94)90085-x | en |
dc.references | Ward-Ritacco CL, Adrian AL, O’Connor PJ, Binkowski JA, Rogers LQ, Johnson MA, et al. 2015. Feelings of Energy are Associated with Physical Activity and Sleep Quality, But Not Adiposity, in Middle-Aged Postmenopausal Women. Menopause 22(3):304–311. https://doi.org/10.1097/GME.0000000000000315 | en |
dc.references | Weidner K, Bittner A, Beutel M, Goeckenjan M, Brähler E, Garthus-Niegel S. 2020. The role of stress and self-efficacy in somatic and psychological symptoms during the climacteric period – Is there a specific association? Maturitas 136:1–6. https://doi.org/10.1016/j.maturitas.2020.03.004 | en |
dc.references | Woods R, Hess R, Biddington C, Federico M. 2020. Association of lean body mass to menopausal symptoms: The Study of Women’s Health Across the Nation. Womens Midlife Health 6:10. https://doi.org/10.1186/s40695-020-00058-9 | en |
dc.references | Wright L, Simpson W, Van Lieshout RJ, Steiner M. 2014. Depression and cardiovascular disease in women: is there a common immunological basis?A theoretical synthesis. Ther Adv Cardiovasc Dis 8(2):56–69. https://doi.org/10.1177/1753944714521671 | en |
dc.references | Yaylali GF, Tekekoglu S, Akin F. 2010. Sexual Dysfunction in Obese and Overweight Women. Int J Impot Res 22(4):220–226. https://doi.org/10.1038/ijir.2010.7 | en |
dc.references | Zhu D, Chung HF, Dobson AJ,Pandeya N, Anderson DJ, Kuh D et al. 2020.Vasomotor menopausal symptoms and risk of cardiovascular disease: A pooled analysis of six prospective studies. Am J Obstet Gynecol 223 (6): 898 e1–898 e16. https://doi.org/10.1016/j.ajog.2020.06.039 | en |
dc.references | Zhu F, Chen M, Xiao Y, Huang X, Chen L, Hong L. 2024. Synergistic interaction between hyperlipidemia and obesity as a risk factor for stress urinary incontinence in Americans. Sci Rep 14: 7312. https://doi.org/10.1038/s41598-024-56744-5 | en |
dc.contributor.authorEmail | Kar, Debasmita - kar92debasmita@gmail.com | |
dc.contributor.authorEmail | Roy, Subho - srayanth@gmail.com | |
dc.identifier.doi | 10.18778/1898-6773.87.2.07 | |
dc.relation.volume | 87 | |